Cargando…

Drug resistance related to aberrant glycosylation in colorectal cancer

Colorectal cancer (CRC) is the fourth leading cause of cancer-related deaths in the world. Drug resistance of tumour cells remains the main challenge toward curative treatments efficiency. Several epidemiologic studies link emergence and recurrence of this cancer to metabolic disorders. Glycosylatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Very, Ninon, Lefebvre, Tony, El Yazidi-Belkoura, Ikram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787446/ https://www.ncbi.nlm.nih.gov/pubmed/29416702 http://dx.doi.org/10.18632/oncotarget.22377

Ejemplares similares

Targeting O-GlcNAcylation to overcome resistance to anti-cancer therapies
por: Very, Ninon, et al.
Publicado: (2022)

Cross-Dysregulation of O-GlcNAcylation and PI3K/AKT/mTOR Axis in Human Chronic Diseases
por: Very, Ninon, et al.
Publicado: (2018)

Evaluation of the expression of fatty acid synthase and O-GlcNAc transferase in patients with liver cancer by exploration of transcriptome databases and experimental approaches
por: Raab, Sadia, et al.
Publicado: (2022)

O-GlcNAcylation Links Nutrition to the Epigenetic Downregulation of UNC5A during Colon Carcinogenesis
por: Decourcelle, Amélie, et al.
Publicado: (2020)

Silencing the Nucleocytoplasmic O-GlcNAc Transferase Reduces Proliferation, Adhesion, and Migration of Cancer and Fetal Human Colon Cell Lines
por: Steenackers, Agata, et al.
Publicado: (2016)

Aberrant glycosylation in colorectal cancer with genomic and epigenomic alterations
por: Okayama, Hirokazu, et al.
Publicado: (2018)

Epigenetic Bases of Aberrant Glycosylation in Cancer
por: Dall’Olio, Fabio, et al.
Publicado: (2017)

Involvement of Aberrant Glycosylation in Thyroid Cancer
por: Miyoshi, Eiji, et al.
Publicado: (2010)

Aberrant O‐glycosylation contributes to tumorigenesis in human colorectal cancer
por: Jiang, Yuliang, et al.
Publicado: (2018)

Aberrant glycosylation associated with enzymes as cancer biomarkers
por: Meany, Danni L, et al.
Publicado: (2011)

Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43
por: Tuccillo, Franca Maria, et al.
Publicado: (2014)

Warning Signs From the Crypt: Aberrant Protein Glycosylation Marks Opportunities for Early Colorectal Cancer Detection
por: Chandrasekar, Dharini, et al.
Publicado: (2023)

Astrocytes express aberrant immunoglobulins as putative gatekeeper of astrocytes to neuronal progenitor conversion
por: Capuz, Alice, et al.
Publicado: (2023)

Aberrant Glycosylation as Immune Therapeutic Targets for Solid Tumors
por: Matsumoto, Yasuyuki, et al.
Publicado: (2023)

Aberrant RNA Splicing in Cancer and Drug Resistance
por: Wang, Bi-Dar, et al.
Publicado: (2018)

Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against Cancer
por: Vasconcelos-dos-Santos, Andréia, et al.
Publicado: (2015)

Role of aberrant glycosylation enzymes in oral cancer progression
por: Vajaria, Bhairavi N., et al.
Publicado: (2018)

Aberrant splicing and drug resistance in AML
por: de Necochea-Campion, Rosalia, et al.
Publicado: (2016)

Serum-stimulated cell cycle entry promotes ncOGT synthesis required for cyclin D expression
por: Olivier-Van Stichelen, S, et al.
Publicado: (2012)

Direct analysis of aberrant glycosylation on haptoglobin in patients with gastric cancer
por: Kim, Jae-Han, et al.
Publicado: (2016)

Aberrant O-glycosylation modulates aggressiveness in neuroblastoma
por: Cuello, Hector A., et al.
Publicado: (2018)

A Cancer-specific Monoclonal Antibody Recognizes the Aberrantly Glycosylated Podoplanin
por: Kato, Yukinari, et al.
Publicado: (2014)

COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer
por: Hofmann, Bianca T., et al.
Publicado: (2015)

Diagnosis and activity assessment of immunoglobulin A nephropathy: current perspectives on noninvasive testing with aberrantly glycosylated immunoglobulin A-related biomarkers
por: Suzuki, Yusuke, et al.
Publicado: (2014)

Aberrantly Glycosylated IgA1 as a Factor in the Pathogenesis of IgA Nephropathy
por: Tanaka, Mototsugu, et al.
Publicado: (2011)

Aberrant HMGA2 Expression Sustains Genome Instability That Promotes Metastasis and Therapeutic Resistance in Colorectal Cancer
por: Campos Gudiño, Rubi, et al.
Publicado: (2023)

Aberrant Glycosylation Augments the Immuno-Stimulatory Activities of Soluble Calreticulin
por: Gong, Fang-Yuan, et al.
Publicado: (2018)

Drug resistance and new therapies in colorectal cancer
por: Van der Jeught, Kevin, et al.
Publicado: (2018)

N-glycosylation Regulates Intrinsic IFN-γ Resistance in Colorectal Cancer: Implications for Immunotherapy
por: Krug, Julia, et al.
Publicado: (2023)

Characterization of aberrant glycosylation associated with osteoarthritis based on integrated glycomics methods
por: Yu, Hanjie, et al.
Publicado: (2023)

Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond
por: Al Bitar, Samar, et al.
Publicado: (2023)

Hallmarks of glycosylation in cancer
por: Munkley, Jennifer, et al.
Publicado: (2016)

Drug Resistance in Colorectal Cancer: From Mechanism to Clinic
por: Wang, Qianyu, et al.
Publicado: (2022)

Glycosylation of plasma IgG in colorectal cancer prognosis
por: Theodoratou, Evropi, et al.
Publicado: (2016)

Identification of O-glycosylated Proteins That Are Aberrantly Excreted in the Urine of Patients with Early Stage Ovarian Cancer
por: Mu, Alan Kang-Wai, et al.
Publicado: (2013)

Cancer Associated Aberrant Protein O-Glycosylation Can Modify Antigen Processing and Immune Response
por: Madsen, Caroline B., et al.
Publicado: (2012)

Distinct signatures of lung cancer types: aberrant mucin O-glycosylation and compromised immune response
por: Lucchetta, Marta, et al.
Publicado: (2019)

Aberrant Drug-Related Behavior Monitoring
por: Maumus, Marianne, et al.
Publicado: (2020)

Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don’t Know
por: Ohyama, Yukako, et al.
Publicado: (2021)

Aberrant Glycosylation in the Left Ventricle and Plasma of Rats with Cardiac Hypertrophy and Heart Failure
por: Nagai-Okatani, Chiaki, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mkjurrueecqtltqtd2kuebcni5